These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28961705)

  • 1. Rifampicin potentiation of aminoglycoside activity against cystic fibrosis isolates of Pseudomonas aeruginosa.
    Mikalauskas A; Parkins MD; Poole K
    J Antimicrob Chemother; 2017 Dec; 72(12):3349-3352. PubMed ID: 28961705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meropenem potentiation of aminoglycoside activity against Pseudomonas aeruginosa: involvement of the MexXY-OprM multidrug efflux system.
    Poole K; Gilmour C; Farha MA; Parkins MD; Klinoski R; Brown ED
    J Antimicrob Chemother; 2018 May; 73(5):1247-1255. PubMed ID: 29420743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of Aminoglycoside Activity in Pseudomonas aeruginosa by Targeting the AmgRS Envelope Stress-Responsive Two-Component System.
    Poole K; Gilmour C; Farha MA; Mullen E; Lau CH; Brown ED
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3509-18. PubMed ID: 27021319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational activation of the AmgRS two-component system in aminoglycoside-resistant Pseudomonas aeruginosa.
    Lau CH; Fraud S; Jones M; Peterson SN; Poole K
    Antimicrob Agents Chemother; 2013 May; 57(5):2243-51. PubMed ID: 23459488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the multidrug efflux system MexXY in the emergence of moderate resistance to aminoglycosides among Pseudomonas aeruginosa isolates from patients with cystic fibrosis.
    Vogne C; Aires JR; Bailly C; Hocquet D; Plésiat P
    Antimicrob Agents Chemother; 2004 May; 48(5):1676-80. PubMed ID: 15105120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The aminoglycoside resistance-promoting AmgRS envelope stress-responsive two-component system in Pseudomonas aeruginosa is zinc-activated and protects cells from zinc-promoted membrane damage.
    Poole K; Hay T; Gilmour C; Fruci M
    Microbiology (Reading); 2019 May; 165(5):563-571. PubMed ID: 30835196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosomal mechanisms of aminoglycoside resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Islam S; Oh H; Jalal S; Karpati F; Ciofu O; Høiby N; Wretlind B
    Clin Microbiol Infect; 2009 Jan; 15(1):60-6. PubMed ID: 19154484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa.
    Hu YF; Liu CP; Wang NY; Shih SC
    BMC Infect Dis; 2016 Aug; 16(1):444. PubMed ID: 27553962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MexXY efflux pump overexpression and aminoglycoside resistance in cystic fibrosis isolates of Pseudomonas aeruginosa from chronic infections.
    Singh M; Yau YCW; Wang S; Waters V; Kumar A
    Can J Microbiol; 2017 Dec; 63(12):929-938. PubMed ID: 28922614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of rifampicin on adaptive resistance of Pseudomonas aeruginosa to aminoglycosides.
    Xiong YQ; Caillon J; Drugeon H; Potel G; Baron D
    J Antimicrob Chemother; 1996 May; 37(5):993-8. PubMed ID: 8737149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Pseudomonas aeruginosa infection in individuals with cystic fibrosis: is susceptibility testing justified?
    Macdonald D; Cuthbertson L; Doherty C; Campana S; Ravenni N; Taccetti G; Govan JR
    J Antimicrob Chemother; 2010 Nov; 65(11):2373-5. PubMed ID: 20837573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of rifampicin on the in-vitro activity of cefpirome or ceftazidime in combination with aminoglycosides against Pseudomonas aeruginosa.
    Valdes JM; Baltch AL; Smith RP; Hammer MC; Ritz WJ
    J Antimicrob Chemother; 1990 Apr; 25(4):575-84. PubMed ID: 2112539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the MexXY multidrug efflux pump in moderate aminoglycoside resistance in Pseudomonas aeruginosa isolates from Pseudomonas mastitis.
    Chuanchuen R; Wannaprasat W; Ajariyakhajorn K; Schweizer HP
    Microbiol Immunol; 2008 Aug; 52(8):392-8. PubMed ID: 18667038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MICs of rifampicin and chloramphenicol for mucoid Pseudomonas aeruginosa strains are lower when human lactoferrin is present.
    Fowler CE; Soothill JS; Oakes L
    J Antimicrob Chemother; 1997 Dec; 40(6):877-9. PubMed ID: 9462441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial activity of tobramycin against respiratory cystic fibrosis Pseudomonas aeruginosa isolates from Bulgaria.
    Strateva T; Petrova G; Mitov I
    J Chemother; 2010 Dec; 22(6):378-83. PubMed ID: 21303744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Routine susceptibility testing of four antibiotic combinations for improvement of laboratory guide to therapy of cystic fibrosis infections caused by Pseudomonas aeruginosa.
    Weiss K; Lapointe JR
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2411-4. PubMed ID: 8585718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integron types, antimicrobial resistance genes, virulence gene profile, alginate production and biofilm formation in Iranian cystic fibrosis Pseudomonas aeruginosa isolates.
    Pournajaf A; Razavi S; Irajian G; Ardebili A; Erfani Y; Solgi S; Yaghoubi S; Rasaeian A; Yahyapour Y; Kafshgari R; Shoja S; Rajabnia R
    Infez Med; 2018 Sep; 26(3):226-236. PubMed ID: 30246765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does ivacaftor interfere with the antimicrobial activity of commonly used antibiotics against Pseudomonas aeruginosa?-Results of an in vitro study.
    Millar BC; Rendall JC; Downey DG; Moore JE
    J Clin Pharm Ther; 2018 Dec; 43(6):836-843. PubMed ID: 29959786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Draft genome sequence of an aminoglycoside-resistant RmtG-producing Pseudomonas aeruginosa ST235 isolated from a cystic fibrosis patient.
    Bueno MFC; Francisco GR; Cerdeira L; Ienne S; Souza TA; Lincopan N; de Oliveira Garcia D
    J Glob Antimicrob Resist; 2017 Mar; 8():106-107. PubMed ID: 28082143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.